Fig. 1: Overview of study cohort and proteomic platforms. | Communications Chemistry

Fig. 1: Overview of study cohort and proteomic platforms.

From: Current landscape of plasma proteomics from technical innovations to biological insights and biomarker discovery

Fig. 1

Plasma samples collected via plasmapheresis from aged (n = 40) and young (n = 38) subjects were analyzed using eight proteomic platforms: SomaScan 11K, SomaScan 7K, Olink 5K (Olink Explore HT), Olink 3K (Olink Explore 3072), MS-HAP Depletion (high-abundance protein depletion), MS-Nanoparticle (Seer Proteograph™ XT), MS-IS Targeted (SureQuant™ Internal Standard Triggered - Parallel Reaction Monitoring) and NULISA (NULISAseq™ Inflammation Panel 250 and NULISAseq™ CNS Disease Panel 120).

Back to article page